Actively Recruiting
Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol
Led by October University for Modern Sciences and Arts · Updated on 2024-12-20
44
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth
CONDITIONS
Official Title
Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 4 and 9 years old
- Primary molars with no spontaneous or provoked pain
- Primary molars with at least two-thirds of root length present
- Primary molars showing no signs of internal or other root or bone resorption
You will not qualify if you...
- Presence of systemic diseases such as congenital or rheumatic heart disease, hepatitis, nephritis, tumor, cyclic neutropenia, leukemia, or long-term corticosteroid therapy
- Uncooperative patients
- Unrestorable primary molars, including grossly broken-down teeth with decay extending under the gum or teeth with root caries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MSA University
El-Sheikh Zayed City, Giza Governorate, Egypt, 16672
Actively Recruiting
Research Team
M
Marwa A Salamon, Ph.D
CONTACT
M
Marwa A Salmoon, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here